The FY2025 (Dec) proxy of Harrow names 16 peer companies for pay. Pay versus performance data of Harrow for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Ocular Therapeutix | ||
| Mirum Pharmaceuticals | ||
| Ardelyx | ||
| Staar Surgical | ||
| Tarsus Pharmaceuticals | ||
| Agios Pharmaceuticals | ||
| Ani Pharmaceuticals | Not disclosed | Not disclosed |
| Arrowhead Pharmaceuticals | Not disclosed | Not disclosed |
| Dynavax Technologies | Not disclosed | Not disclosed |
| Eyepoint Pharmaceuticals | Not disclosed | Not disclosed |
| Heron Therapeutics | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals | Not disclosed | Not disclosed |
| Rigal Pharmaceuticals | Not disclosed | Not disclosed |
| RxSight | Not disclosed | Not disclosed |
| Theravance Biopharma | Not disclosed | Not disclosed |
| Xeris Biopharma Holdings | Not disclosed | Not disclosed |
16 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.